Altimmune, Inc.
Coronavirus immunogenic compositions and uses thereof
Last updated:
Abstract:
Provided in the present disclosure are immunogenic compounds, pharmaceutical formulations thereof and their use for inducing a protective immune response against 2019 novel coronavirus (SARS-CoV-2) infection and variants in a mammal.
Status:
Grant
Type:
Utility
Filling date:
9 Jun 2021
Issue date:
12 Jul 2022